245 related articles for article (PubMed ID: 20616602)
1. Real practice of hepatocellular carcinoma in Japan: conclusions of the Japan Society of Hepatology 2009 Kobe Congress.
Kudo M
Oncology; 2010 Jul; 78 Suppl 1():180-8. PubMed ID: 20616602
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and treatment algorithm of the Japanese society of hepatology: a consensus-based practice guideline.
Izumi N
Oncology; 2010 Jul; 78 Suppl 1():78-86. PubMed ID: 20616588
[TBL] [Abstract][Full Text] [Related]
3. Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology.
Kudo M; Okanoue T;
Oncology; 2007; 72 Suppl 1():2-15. PubMed ID: 18087177
[TBL] [Abstract][Full Text] [Related]
4. A modified TNM-based Japan Integrated Score combined with AFP level may serve as a better staging system for early-stage predominant hepatocellular carcinoma patients.
Yen YH; Changchien CS; Wang JH; Kee KM; Hung CH; Hu TH; Lee CM; Lin CY; Wang CC; Chen TY; Huang YJ; Lu SN
Dig Liver Dis; 2009 Jun; 41(6):431-41. PubMed ID: 19185555
[TBL] [Abstract][Full Text] [Related]
5. Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).
Kudo M; Chung H; Osaki Y
J Gastroenterol; 2003; 38(3):207-15. PubMed ID: 12673442
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of liver transplantation in 490 patients with hepatocellular carcinoma: validation of a uniform staging after surgical treatment.
Vauthey JN; Ribero D; Abdalla EK; Jonas S; Bharat A; Schumacher G; Lerut J; Chapman WC; Hemming AW; Neuhaus P
J Am Coll Surg; 2007 May; 204(5):1016-27; discussion 1027-8. PubMed ID: 17481532
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular carcinoma 2009 and beyond: from the surveillance to molecular targeted therapy.
Kudo M
Oncology; 2008; 75 Suppl 1():1-12. PubMed ID: 19092266
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of the clinical practice guidelines for hepatocellular carcinoma in Japan and Western countries].
Ikai I
Nihon Geka Gakkai Zasshi; 2008 Nov; 109(6):343-8. PubMed ID: 19068716
[TBL] [Abstract][Full Text] [Related]
9. Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version.
Kudo M; Izumi N; Kokudo N; Matsui O; Sakamoto M; Nakashima O; Kojiro M; Makuuchi M;
Dig Dis; 2011; 29(3):339-64. PubMed ID: 21829027
[TBL] [Abstract][Full Text] [Related]
10. [The diagnostic approach to hepatocellular carcinoma].
Schacherer D; Schoelmerich J; Zuber-Jerger I
Z Gastroenterol; 2007 Oct; 45(10):1067-74. PubMed ID: 17924305
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of survival of patients with hepatocellular carcinoma predicted by different staging systems using multivariate analysis.
Nanashima A; Omagari K; Tobinaga S; Shibata K; Sumida Y; Mine M; Morino S; Shibasaki S; Ide N; Shindou H; Nagayasu T
Eur J Surg Oncol; 2005 Oct; 31(8):882-90. PubMed ID: 15993031
[TBL] [Abstract][Full Text] [Related]
12. [Diagnostics and treatment of hepatocellular carcinoma. Recommendations of the Portal Hypertension Working Group of the Czech Hepatology Society and the J.E. Purkinje Czech Medical Society ].
Brůha R; Drastich P; Hůlek P; Lata J; Petrtýl J; Procházka J; Spicák J; Vanásek T; Volfová M; Zdenek P;
Vnitr Lek; 2005 Dec; 51(12):1406-8. PubMed ID: 16430109
[TBL] [Abstract][Full Text] [Related]
13. The Japanese integrated staging score using liver damage grade for hepatocellular carcinoma in patients after hepatectomy.
Nanashima A; Sumida Y; Morino S; Yamaguchi H; Tanaka K; Shibasaki S; Ide N; Sawai T; Yasutake T; Nakagoe T; Nagayasu T
Eur J Surg Oncol; 2004 Sep; 30(7):765-70. PubMed ID: 15296991
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of treatment methods for hepatocellular carcinoma--based on JIS score].
Kudo M; Chung H; Osaki Y; Kasugai H; Oka H; Seki T
Gan To Kagaku Ryoho; 2004 Dec; 31(13):2100-4. PubMed ID: 15628751
[TBL] [Abstract][Full Text] [Related]
15. Role of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in the management of hepatocellular carcinoma: consensus at the Symposium of the 48th Annual Meeting of the Liver Cancer Study Group of Japan.
Kudo M; Matsui O; Sakamoto M; Kitao A; Kim T; Ariizumi S; Ichikawa T; Kobayashi S; Imai Y; Izumi N; Fujinaga Y; Arii S
Oncology; 2013; 84 Suppl 1():21-7. PubMed ID: 23428854
[TBL] [Abstract][Full Text] [Related]
16. The model for end-stage liver disease-based Japan Integrated Scoring system may have a better predictive ability for patients with hepatocellular carcinoma undergoing locoregional therapy.
Huo TI; Lin HC; Huang YH; Wu JC; Chiang JH; Lee PC; Lee SD
Cancer; 2006 Jul; 107(1):141-8. PubMed ID: 16708358
[TBL] [Abstract][Full Text] [Related]
17. Comparison of three current staging systems for hepatocellular carcinoma: Japan integrated staging score, new Barcelona Clinic Liver Cancer staging classification, and Tokyo score.
Chung H; Kudo M; Takahashi S; Hagiwara S; Sakaguchi Y; Inoue T; Minami Y; Ueshima K; Fukunaga T; Matsunaga T
J Gastroenterol Hepatol; 2008 Mar; 23(3):445-52. PubMed ID: 17683486
[TBL] [Abstract][Full Text] [Related]
18. Modern diagnosis and management of hepatocellular carcinoma.
Marrero JA; Welling T
Clin Liver Dis; 2009 May; 13(2):233-47. PubMed ID: 19442916
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis and multimodal therapy for hepatocellular carcinoma].
Kolligs FT; Hoffmann RT; op den Winkel M; Bruns CJ; Herrmann K; Jakobs TF; Lamerz R; Trumm C; Zech CJ; Wilkowski R; Graeb C
Z Gastroenterol; 2010 Feb; 48(2):274-88. PubMed ID: 20119895
[TBL] [Abstract][Full Text] [Related]
20. [Practice guidelines for management of hepatocellular carcinoma 2009].
Korean Liver Cancer Study Group and National Cancer Center, Korea
Korean J Hepatol; 2009 Sep; 15(3):391-423. PubMed ID: 19783891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
